Abstract

Oral cancer is among the most common malignancies worldwide, therefore early detection and treatment is imperative. The 5-year survival rate has remained at a dismal 50% for the past several decades. The main reason for the poor survival rate is the fact that most of the oral cancers, despite the general accessibility of the oral cavity, are not diagnosed until the advanced stage. Early detection of the oral tumors and its precursor lesions may be the most effective means to improve clinical outcome and cure most patients. One of the emerging technologies is the use of non-invasive in vivo tissue imaging to capture the molecular changes at high-resolution to improve the detection capability of early stage disease. This review will discuss the use of optical probes and highlight the role of optical imaging such as autofluorescence, fluorescence diagnosis (FD), laser confocal endomicroscopy (LCE), surface enhanced Raman spectroscopy (SERS), optical coherence tomography (OCT) and confocal reflectance microscopy (CRM) in early oral cancer detection. FD is a promising method to differentiate cancerous lesions from benign, thus helping in the determination of adequate resolution of surgical resection margin. LCE offers in vivo cellular imaging of tissue structures from surface to subsurface layers and has demonstrated the potential to be used as a minimally invasive optical biopsy technique for early diagnosis of oral cancer lesions. SERS was able to differentiate between normal and oral cancer patients based on the spectra acquired from saliva of patients. OCT has been used to visualize the detailed histological features of the oral lesions with an imaging depth down to 2–3 mm. CRM is an optical tool to noninvasively image tissue with near histological resolution. These comprehensive diagnostic modalities can also be used to define surgical margin and to provide a direct assessment of the therapeutic effectiveness.

Highlights

  • At 2008, worldwide incidence of oral cancer was numbered at 263,020 cases, and the number of deaths totaled to 127,654

  • The study reported that several commonly occurring conditions, such as mucosal pigmentations, ulcerations, irritations, and gingivitis were associated with a loss of fluorescence using VELscope [31]

  • The results demonstrated that the combination of quantified PPIX fluorescence images with the ratio diagnostic algorithms has the potential for noninvasive diagnosis of early oral cancers in vivo with high diagnostic accuracy

Read more

Summary

Introduction

At 2008, worldwide incidence of oral cancer was numbered at 263,020 cases, and the number of deaths totaled to 127,654. Clinical endoscopic examination and invasive needle biopsies followed by histopathological analysis remains the gold standard for diagnosis and surveillance of oral cavity cancer These conventional techniques has their own limitations such as: (i) difficulty to distinguish benign from malignant lesions; (ii) difficulty in determining margin of lesions; (iii) can be subjective, especially during histopathological analyses; and (iii) tissue biopsies can be invasive and painful for the patients. Computer analysis (Oral CDx) of brush biopsies have been tried in clinical studies, but this again proved inadequate for mass screening, as brush biopsies are again subjective, and suffers from all aforesaid limitations Considering these facts, it is imperative that a new rapid and accurate diagnostic method for early oral cavity cancer detection is much needed to reduce the resulting mortality rate. This review provides description of each of these modalities, mainly in the context of early detection of oral cavity cancer

Probes for Molecular Imaging
Autofluorescence
Fluorescence Diagnosis
Laser Confocal Endomicroscopy
Surface Enhanced Raman Spectroscopy
Optical Coherence Tomography
Confocal Reflectance Microscopy
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call